FDA Adverse Event Malfunction Summary report: N

CHECK-IT

MDR report key: 14438053 · Received May 19, 2022

Report

Report Number
3016521623-2022-00191
Event Type
Malfunction
Date Received
May 19, 2022
Date of Event
May 4, 2022
Report Date
May 16, 2022
Manufacturer
LUCIRA HEALTH, INC.
Product Code
QJR
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

PRODUCT WAS NOT RETURNED. A DHR REVIEW OF THE ASSOCIATED KIT LOT# K07A110601224M1 WERE COMPLETED WITH 0 DISCREPANCIES FOUND (ALL LOTS PASSED IN TOTAL PER THE SAMPLING PLAN). A REVIEW OF EXISTING CAPAS, SCARS AND NCMRS WERE COMPLETED AND THERE ARE NO PRIOR RECORDS RELATED TO "FALSE NEGATIVE" FAILURE MODE FOR THIS LOT. THERE ARE 0 ADDITIONAL COMPLAINTS FROM THIS CUSTOMER ASSOCIATED WITH A "FALSE NEGATIVE" FAILURE MODE. BASED ON REVIEW OF THE PRODUCT'S FMEAS AND RISK ASSESSMENT DOCUMENTATION, FALSE NEGATIVE TEST RESULTS ARE A KNOWN POSSIBLE OUTCOME REGARDING THIS ISSUE UNDER EVALUATION, REFER TO FMEA-004. THE COMPLAINT RATE FOR FALSE NEGATIVES IS UNDER THE EXPECTED THRESHOLD OF (B)(4) (LABEL CLAIM)/ (B)(4) (INTERNAL WARNING LIMIT). LUCIRA HEALTH WILL CONTINUE TO MONITOR TRENDS RELATED TO "FALSE NEGATIVE" RESULTS IN ACCORDANCE WITH POST-MARKET SURVEILLANCE PROCESS. KIT LOT# K07A110601224M1 DHR REVIEW REFERENCE: SAMPLE VIAL LOT DHR REVIEW: 2112059, 2112150, 2112166, 2112167, 2112189, 2112199, 2112229, 2112293, 2112259, 2112294, 2112260, 2112261, 2112317, 2112318, 2112058 (ASSOCIATED INTERNAL LOT # 211087-3H, 211087-3N, 211087-3P, 211087-3Q, 211087-3T, 211087-2W, 211087-2Y, 211087-4O, 211087-4B, 211087-4C, 211087-4G, 211087-4H, 211087-4M, 211087-4N, 211087-3G). TEST LOT DHRS REVIEW: 2112128, 2112128, 2112158, 2112174, 2112174, 2112174, 2112192, 2112192, 2112210, 2112212, 2112248, 2112302, 2112327, 2112356, 2112405, 2112047, 2112047, 2112107, 2112107 (ASSOCIATED INTERNAL LOT 211275-2C, 211275-2D, 211275-2E, 211275-2F, 211275-2H, 211275-2J, 211275-2L, 211275-2N, 211275-2O, 211275-2Q, 211275-2S, 211275-2X, 2114921-1A, 2114921-1I, 2114921-1N, 211275-1W, 211275-1X, 211275-2A, 211275-2B). BASED ON THE LIMITED INFORMATION AVAILABLE, ROOT CAUSE CANNOT BE DETERMINED. POTENTIAL ROOT CAUSES INCLUDE BUT ARE NOT LIMITED TO: ENVIRONMENTAL CONTAMINATION, LOW VIRAL LOAD, AND/OR DEVICE FAILURE. BASED ON THE COMPLAINT REVIEW, NO HARM WAS REPORTED WITHIN THE COMPLAINT. A SUPPLEMENTAL REPORT WILL BE FILED IF ANY FURTHER INVESTIGATION AND/OR ADDITIONAL INFORMATION IS OBTAINED. THIS DEVICE IS MARKETED UNDER EUA (B)(4) CHECK-IT.

Description of Event or Problem · 0

ONCE DEVICE REPORTED AS HAVING A FALSE NEGATIVE RESULT. THE COMPLAINANT PERFORMED TWO LUCIRA TESTS, ONE WITH A POSITIVE RESULT AND ONE WITH A NEGATIVE RESULT. THE COMPLAINANT FOLLOWED-UP WITH TAKING A LAB PCR TEST WITH A POSITIVE RESULT FOR CONFIRMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1976065 CHECK-IT COVID-19 TEST KIT QJR LUCIRA HEALTH, INC. K07A110601224M1

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other